Mercy BioAnalytics: Dawn Mattoon
Dawn Mattoon has been appointed as chief operating officer of liquid biopsy cancer detection firm Mercy BioAnalytics. Most recently, she was senior VP of clinical diagnostics at Quanterix. Before that, she held positions in R&D, strategy, and general management at Invitrogen, Life Technologies, and Thermo Fisher Scientific. Mattoon holds a PhD in molecular genetics from Yale University.